» Articles » PMID: 33747111

Antihypertensive Effects of the (Verbenaceae) Stem-Bark Extract on L-NAME-Induced Hypertensive Rats

Overview
Date 2021 Mar 22
PMID 33747111
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

stem-bark is used in Cameroonian traditional medicine to treat cardiovascular diseases including hypertension. In previous studies, the methanol/methylene chloride stem-bark extract of (MMVC) showed a preventive activity in L-NAME-induced hypertension and improved blood pressure of spontaneously hypertensive rats. The present study investigated the curative effects in L-NAME-induced hypertensive rats (LNHR). Hypertension was induced in rats by oral administration of L-NAME (40 mg/kg/day) for 28 days. The animals were divided into 2 groups: one group of 5 rats receiving distilled water (10 ml/kg) and another 20 rats receiving L-NAME. At the end of 4 weeks of administration of L-NAME, the animals were divided into 4 groups of 5 rats each: one group of hypertensive rats receiving distilled water, another one receiving captopril (25 mg/kg), and two groups of hypertensive rats receiving MMVC at doses of 200 and 400 mg/kg, respectively. Body weight, food, and water intake were measured weekly. At the end of the treatment, blood pressure and heart rate were recorded by invasive method. Whole heart, left ventricle, kidneys, and liver were weighed. The effects of plant extract on lipid profile and oxidative stress markers, as well as markers of hepatic and renal functions were assessed spectrophotometrically according to well described protocols. Results show that L-NAME significantly increases the mean arterial blood pressure (MABP), atherogenic index, lipid profile, and creatinine and transaminase activities of normotensive rats. MMVC significantly reduced the blood pressure in LNHR. Body weight, food and water intake, left ventricular hypertrophy, antioxidant level, renal and hepatic markers, and lipid profile were improved by the treatment with MMVC. The curative effect of MMVC on L-NAME-induced hypertension is probably related to its antihypertensive, hypolipidemic, and antioxidant properties. These results confirmed the use of for the treatment of hypertension in traditional medicine.

Citing Articles

Drying temperature affects the hypolipidemic, antioxidant, and antihypertensive potential of calyx in rats induced with L-NAME.

Efosa J, Omage K, Azeke M Toxicol Rep. 2023; 11:177-188.

PMID: 37719201 PMC: 10504460. DOI: 10.1016/j.toxrep.2023.09.005.


Cinnamon modulates the pharmacodynamic & pharmacokinetic of amlodipine in hypertensive rats.

Abdelrahman I, Ahad A, Raish M, Bin Jardan Y, Alam M, Al-Jenoobi F Saudi Pharm J. 2023; 31(9):101737.

PMID: 37638214 PMC: 10458336. DOI: 10.1016/j.jsps.2023.101737.


Pulegone Prevents Hypertension through Activation of Muscarinic Receptors and Cyclooxygenase Pathway in L-NAME-Induced Hypertensive Rats.

Razzaq M, Younis W, Malik M, Alsahli T, Alamgeer , Jahan S Cardiovasc Ther. 2023; 2023:8166840.

PMID: 37214130 PMC: 10195173. DOI: 10.1155/2023/8166840.


species: Bridging empirical knowledge, phytochemistry, nutritional value, health benefits and clinical evidence.

Khatib S, Sobeh M, Faraloni C, Bouissane L Front Pharmacol. 2023; 14:1169629.

PMID: 37153781 PMC: 10157496. DOI: 10.3389/fphar.2023.1169629.


Exerts Antihypertensive Activity in l-NAME-Induced Hypertension Possibly through Modulation of Oxidative Stress, Proinflammatory Cytokines, and the Nitric Oxide/Cyclic Guanosine Monophosphate Pathway.

Shaukat B, Mehmood M, Murtaza B, Javaid F, Khan M, Farrukh M ACS Omega. 2022; 7(37):33307-33319.

PMID: 36157749 PMC: 9494645. DOI: 10.1021/acsomega.2c03888.


References
1.
Tabassum N, Ahmad F . Role of natural herbs in the treatment of hypertension. Pharmacogn Rev. 2011; 5(9):30-40. PMC: 3210006. DOI: 10.4103/0973-7847.79097. View

2.
Rasul Niazi Z, Silva G, Porto Ribeiro T, Leon-Gonzalez A, Kassem M, Mirajkar A . EPA:DHA 6:1 prevents angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase- and COX-derived oxidative stress. Hypertens Res. 2017; 40(12):966-975. DOI: 10.1038/hr.2017.72. View

3.
Basile J . The role of existing and newer calcium channel blockers in the treatment of hypertension. J Clin Hypertens (Greenwich). 2004; 6(11):621-29. PMC: 8109670. DOI: 10.1111/j.1524-6175.2004.03683.x. View

4.
FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

5.
Elnakish M, Hassanain H, Janssen P, Angelos M, Khan M . Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase. J Pathol. 2013; 231(3):290-300. DOI: 10.1002/path.4255. View